A prescription travels from the doctor who writes it, to the pharmacist who dispenses it, with a field representative connecting both. MedShorts gives all three the same accurate, bite-sized science, through one personalised link they can open on any phone.
One new story for each specialty, every morning: short, sourced and readable between patients.
None of today's stories are in your chosen specialties. Change specialties or browse all of MedShorts 360.
CardiologyIn 3,048 Korean ASCVD patients managed to an LDL-C goal, beginning with rosuvastatin plus ezetimibe gave similar 3-year cardiovascular outcomes to starting a statin alone and adding ezetimibe when needed.
DiabetologyA large US health-record analysis presented at AHA 2026 found GLP-1 receptor agonist users with prediabetes and obesity progressed to type 2 diabetes less often than metformin users. The study is observational and not peer reviewed.
NephrologyIn 6,376 patients with atherosclerotic disease, CKD and raised hs-CRP, monthly ziltivekimab lowered inflammatory markers but did not reduce heart attack, stroke or cardiovascular death, nor kidney outcomes, versus placebo.
NeurologyIn 160 stroke survivors with uncontrolled hypertension, a spironolactone-based strategy lowered home systolic pressure by about 8 mm Hg versus usual care at 3 months, with more hypotension and hyperkalaemia. Results are preliminary.
UrologyIn the randomised phase 2 ARACOG trial of 111 men with advanced prostate cancer, objectively measured cognition declined less on darolutamide than on enzalutamide at 48 weeks; patient-reported differences were not statistically significant.
PsychiatryA network meta-analysis of six trials in adults with ADHD and co-occurring stimulant use disorder found that higher-dose methylphenidate and mixed amphetamine salts outperformed placebo on ADHD symptoms and on drug-use measures.
PulmonologyPreviewing the 2027 GOLD report at the GOLD COPD conference, leaders said a long-acting muscarinic antagonist will be the initial choice for group A, alongside revised definitions, an expanded CT section and stronger emphasis on rehabilitation.
Critical CareIn the Lancet PROSpect trial of 424 children with moderate-to-severe paediatric ARDS, neither early prone positioning nor high-frequency oscillatory ventilation increased ventilator-free days, and both carried added safety risks.
GastroenterologyA post hoc analysis of the ATLANTIS trial grouped 401 IBS patients by gut and psychological symptoms; those with mainly psychological symptoms gained most from low-dose amitriptyline, while the most severe group stopped treatment more often.
DermatologyIn a 43-patient sub-study of a randomised trial, 12 weeks of abrocitinib 100 mg or 200 mg was associated with dose-dependent falls in skin S. aureus and a shift towards a healthier skin microbiome compared with placebo.
OphthalmologyA GWAS meta-analysis of 2,584 CSC cases and over 1 million controls found 10 risk loci, 3 of them new, with risk concentrated in scleral fibroblasts and vascular endothelial cells, supporting CSC as a primary sclerovascular disorder.
ENTA US case-control study of 3,600 sinonasal cancer cases and 17,695 controls found that each SD rise in regional PM2.5 was linked to 25% to 36% higher odds of diagnosis, with stronger links for longer exposure windows.
OrthopaedicsA BMJ network meta-analysis of 189 trials in nearly 13,000 adults with frozen shoulder found moderate-certainty evidence that shockwave therapy eases short-term pain and manipulation under anaesthesia improves flexion. Evidence beyond three months is weak.
GynaecologyIn a JAMA Network Open study of nearly 142,000 births in China, both low and high maternal haemoglobin were linked to preterm birth, with risk windows and cut-offs that varied by gestational age and altitude.
PaediatricsIn a South African study of 634 infants scanned in 3D at one month and one year, babies exposed to both alcohol and tobacco throughout pregnancy showed more facial differences than those exposed to either substance alone.
SurgeryIn a JAMA Network Open trial of 100 patients with noninfected Wagner grade 1 diabetic foot ulcers, adding shallow punch incisions to standard care raised 20-week closure from 27.5% to 49.0%, a low-cost adjunct needing confirmation.
General MedicineIn a JAMA cluster randomised trial of 1,706 adults with uncontrolled hypertension in Colombia and Jamaica, single-pill combinations delivered through team-based care cut systolic BP by 10 mm Hg more than standard care at 18 months.
Add MedShorts to your phone's home screen: today's stories in one tap, full screen, no app store needed.
Indian pharma has traditionally put almost all of its scientific effort into one moment: the representative's few minutes with a doctor. Yet outcomes depend on much more than that moment. The pharmacist decides how a medicine is explained, substituted and taken. The representative's own confidence in the science shapes every conversation. And the doctor, seeing dozens of patients a day, needs updates that fit between consultations, not another hour-long webinar.
MedShorts began as a smart way to send doctors a personalised content library through a single link. We are now extending it into a broader strategic initiative: a knowledge network that serves the doctor, the pharmacist and the field force together, with consistent science, the right depth for each role, and one view of engagement for the brand team.
The result is fewer disconnected campaigns and more joined-up education, where the doctor's prescription, the pharmacist's counselling and the representative's message all say the same thing.
Each audience gets its own experience, written for how they work and what they need to decide, while the science underneath stays the same.
Short clinical updates, guideline summaries, journal digests and KOL perspectives, curated by specialty and delivered to the phone.
Practical capsules on dosing, interactions, storage, adherence and safety, written for community and hospital pharmacists.
Micro-learning on disease, molecule and evidence, with assessments, certification and approved links representatives can share with doctors.
When all three roles learn from the same source, the patient hears one consistent story about their treatment.
Learns the evidence, passes certification, shares an approved MedShorts link.
Reviews the update in minutes, prescribes with the latest guidance, shares patient material.
Dispenses correctly and counsels on dose, timing, side-effects and adherence.
Every piece is written from published evidence and guidelines, reviewed by our medical team and kept to the length a busy clinician will actually finish.
Personalised links by SMS, email and WhatsApp, QR codes at pharmacies and clinics, and representative-shared links. No app to download.
Quizzes, case challenges and certification turn content into measurable learning, with deeper courses on Medigene Learn.
Open, read-through, video-completion and quiz data by audience, specialty and region, reported in one dashboard.
Medical and regulatory review, content aligned with the approved prescribing information, consent-based contact and data handled under India's data-protection law.
Designed for low-bandwidth mobile use, with English and Hindi as standard and regional languages for pharmacist and patient material.
A personalised MedShorts link arrives by SMS, email or WhatsApp, or is shared by a representative.
One tap opens a secure, mobile-friendly library. A one-time registration keeps it personal.
Short articles, videos, infographics and quizzes, chosen for the reader's role and specialty.
Apply it in practice, share patient material, or continue to a full CME course.
Engagement flows into the brand dashboard and shapes the next content cycle.
Two-to-three-minute reads on a single clinical question.
Expert perspectives in three-to-five-minute clips.
Landmark and recent trials summarised with key numbers.
What changed, and what it means in clinic.
Test and reinforce, with instant explanations.
Leaflets and videos doctors and pharmacists can share.
Lung-sound and ECG trainers, calculators and checklists.
Interaction, storage and pharmacovigilance reminders.
MedShorts already hosts series in neurology, cardio-metabolic care, respiratory medicine, orthopaedics, oncology, women's health, critical care, dermatology, dentistry and ophthalmology, including interactive trainers for lung sounds and ECG interpretation.
The new network brings these together in one library and adds dedicated tracks for pharmacists and field teams.
Talk to us about a MedShorts programme that reaches your doctors, their pharmacists and your field force with one consistent, compliant message.